Financials
Financial year 2025
INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS from Brussel, company number BE0477556338, closed financial year 2025 with a result of € 117,057 after tax. For that financial year INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS recorded a gross margin of € 715,423 and equity of € 2.3 million. Compared with financial year 2024, the result moved from € 153,064 to € 117,057. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 20, 2026.
€ 2.3 million
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 117,057
▼ 24% vs 2024
Profit after tax over the fiscal year.
€ 1.1 million
▲ 3% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
5.5
▲ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 550,109
▲ 17% vs 2024
€ 100,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,083
▼ 50% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 73,825
▼ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 59,659
▲ 10% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,095,358 | - | - | - | |
| Gross margin | € 456,631 | € 554,260 | € 639,265 | € 715,423 | ▲ 12% |
| Profit after taxes | € -28,830 | € 55,086 | € 153,064 | € 117,057 | ▼ 24% |
| Equity | € 1,982,279 | € 2,037,365 | € 2,190,429 | € 2,307,769 | ▲ 5% |
| Total debts | € 92,698 | € 118,323 | € 150,422 | € 165,484 | ▲ 10% |
| Cash | € 1,920,986 | € 908,977 | € 1,073,511 | € 1,110,040 | ▲ 3% |
| Retained profit | € 1,982,279 | € 2,037,365 | € 2,190,429 | € 2,307,769 | ▲ 5% |
| Balance sheet total | € 2,074,977 | € 2,155,688 | € 2,340,851 | € 2,473,253 | ▲ 6% |
| Employees (FTE) | 4.5 | 4.9 | 5.2 | 5.5 | ▲ 0.3 |
Key figures of INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS?
What happened at INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 117,057 (▼ 24% vs 2024). Source: NBB ↗
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 28,830 loss in 2022 to € 117,057 profit in 2025.
Best year ever: 2024, with € 153,064 profit.
On average € 130,100 of value added per employee in 2025.
A new publication or filing at INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS? We notify you, reason included.
Follow INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS are Lotte Veraart, Jan Berghmans, Hans De Loof, Stijn Lazeure, Veerle Foulon and Kathleen Melotte. Lotte Veraart is also behind Apotheek Kalmthout Veraart, Koninklijke Apothekersvereniging van Antwerpen and Verma Farma.
Directors
According to the 2025 annual accounts
Lotte Veraart
Director
Also active at: Apotheek Kalmthout Veraart, Koninklijke Apothekersvereniging van Antwerpen, Verma Farma
Jan Berghmans
Director
Hans De Loof
Director
Stijn Lazeure
Director
Veerle Foulon
Director
Kathleen Melotte
Director
Also active at: OZOS - Optimale Zorg door Optimale Samenwerking, APOTHEEK MELOTTE, IMMO ENVAN, Easytocare
Marc Lambrecht
Director
Establishments
Establishment units
Physical locations of this company
Tweekerkenstraat 29
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Barracuda
Hosting
AMAZON-02 - Amazon.com, Inc., US
Website info
Features
Security
Details
- Company number
- 0477.556.338
- VAT number
- BE 0477.556.338
- Registered office
- Tweekerkenstraat 29, 1000 Brussel
- Names & denominations
- INSTITUUT VOOR PERMANENTE STUDIE VOOR APOTHEKERS · IPSA
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 7 January 2002
- Peppol
- Active · Active since 18 Mar 2026
- Contact
- ipsa.be [email protected] 022190039
- Activities · NACE
Beroepsopleiding
Volwassenenvorming
Overige vormen van onderwijs
Overige vormen van onderwijs, n.e.g.